The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
Table of Contents
Global Contraceptives Drugs and Devices Market Analysis 2020, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate
1 Market Scope
1.1 Product Details and Introduction
1.1.1 Contraceptive Drugs (Oral Contraceptive Pills, Contraceptive Injectables, Topical Contraceptives) -Product Introduction and Major Manufacturers
1.1.2 Contraceptive Devices (Male Contraceptive Devices, Female Contraceptive Devices) -Product Introduction and Major Manufacturers
1.1.3 -Product Introduction and Major Manufacturers
1.1.4 -Product Introduction and Major Manufacturers
1.1.5 -Product Introduction and Major Manufacturers
1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Regional Market
2.1 Regional Market Share in Terms of Production (2019-2026)
2.2 Regional Market Share in Terms of Revenue (2019-2026)
2.3 Regional Market Share in Terms of Consumption (2019-2026)
3 Global Contraceptives Drugs and Devices Market Assessment by Type
3.1 Global Contraceptives Drugs and Devices Production by Type (2015-2026)
3.2 Global Contraceptives Drugs and Devices Revenue by Type (2015-2026)
3.3 North America Contraceptives Drugs and Devices Production and Revenue by Type (2015-2026)
3.4 Asia Contraceptives Drugs and Devices Production and Revenue by Type (2015-2026)
3.5 Europe Contraceptives Drugs and Devices Production and Revenue by Type (2015-2026)
3.6 Middle East & Africa Contraceptives Drugs and Devices Production and Revenue by Type (2015-2026)
3.7 South America Contraceptives Drugs and Devices Production and Revenue by Type (2015-2026)
4 Global Contraceptives Drugs and Devices Market Assessment by Application
4.1 Historical & Forecast Global Contraceptives Drugs and Devices Consumption, Different Application Field (2015-2026)
4.2 Historical & Forecast North America Contraceptives Drugs and Devices Consumption, Different Application Field (2015-2026)
4.3 Historical & Forecast Asia Contraceptives Drugs and Devices Consumption, Different Application Field (2015-2026)
4.4 Historical & Forecast Europe Contraceptives Drugs and Devices Consumption, Different Application Field (2015-2026)
4.5 Historical & Forecast Middle East & Africa Contraceptives Drugs and Devices Consumption, Different Application Field (2015-2026)
4.6 Historical & Forecast South America Contraceptives Drugs and Devices Consumption, Different Application Field (2015-2026)
5 North America
5.1 US Contraceptives Drugs and Devices Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
5.2 Canada Contraceptives Drugs and Devices Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
5.3 Mexico Contraceptives Drugs and Devices Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
6 Asia
6.1 China Contraceptives Drugs and Devices Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
6.2 Japan Contraceptives Drugs and Devices Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
6.3 India Contraceptives Drugs and Devices Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
6.4 Korea Contraceptives Drugs and Devices Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
6.5 Southeat Asia Contraceptives Drugs and Devices Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
7 Europe
7.1 Germany Contraceptives Drugs and Devices Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
7.2 UK Contraceptives Drugs and Devices Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
7.3 France Contraceptives Drugs and Devices Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
7.4 Russia Contraceptives Drugs and Devices Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
7.5 Italy Contraceptives Drugs and Devices Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
8 Middle East and Africa
8.1 Saudi Contraceptives Drugs and Devices Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
8.2 UAE Contraceptives Drugs and Devices Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
8.3 Egypt Contraceptives Drugs and Devices Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
8.4 Nigeria Contraceptives Drugs and Devices Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
8.5 South Africa Contraceptives Drugs and Devices Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
9 South America
9.1 Brazil Contraceptives Drugs and Devices Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
9.2 Argentina Contraceptives Drugs and Devices Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
9.3 Colombia Contraceptives Drugs and Devices Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
10 Global Contraceptives Drugs and Devices Average Price Trend
10.1 Market Price for Each Type of Contraceptives Drugs and Devices in North America (2015-2026)
10.2 Market Price for Each Type of Contraceptives Drugs and Devices in Asia (2015-2026)
10.3 Market Price for Each Type of Contraceptives Drugs and Devices in Europe (2015-2026)
10.4 Market Price for Each Type of Contraceptives Drugs and Devices in Middle East & Africa (2015-2026)
10.5 Market Price for Each Type of Contraceptives Drugs and Devices in South America (2015-2026)
11 Value Chain (Impact of COVID-19)
11.1 Contraceptives Drugs and Devices Value Chain Analysis
11.1.1 Upstream
11.1.2 Downstream
11.2 COVID-19 Impact on Contraceptives Drugs and Devices Industry
11.2.1 Industrial Policy Issued Under the Epidemic Situation
11.3 Cost-Under the Epidemic Situation
11.3.1 Cost of Raw Material
11.4 Channel Analysis
11.4.1 Distribution Channel-Under the Epidemic Situation
11.4.2 Distributors
12 Contraceptives Drugs and Devices Competitive Analysis
12.1 Teva Pharmaceutical Industries Ltd
12.1.1 Teva Pharmaceutical Industries Ltd Company Profile
12.1.2 Teva Pharmaceutical Industries Ltd Product Introduction
12.1.3 Teva Pharmaceutical Industries Ltd Contraceptives Drugs and Devices Production, Revenue (2015-2020)
12.1.4 SWOT Analysis
12.2 Church & Dwight Co. Inc
12.2.1 Church & Dwight Co. Inc Company Profile
12.2.2 Church & Dwight Co. Inc Product Introduction
12.2.3 Church & Dwight Co. Inc Contraceptives Drugs and Devices Production, Revenue (2015-2020)
12.2.4 SWOT Analysis
12.3 Reckitt Benckiser Plc
12.3.1 Reckitt Benckiser Plc Company Profile
12.3.2 Reckitt Benckiser Plc Product Introduction
12.3.3 Reckitt Benckiser Plc Contraceptives Drugs and Devices Production, Revenue (2015-2020)
12.3.4 SWOT Analysis
12.4 Pfizer
12.4.1 Pfizer Company Profile
12.4.2 Pfizer Product Introduction
12.4.3 Pfizer Contraceptives Drugs and Devices Production, Revenue (2015-2020)
12.4.4 SWOT Analysis
12.5 Inc
12.5.1 Inc Company Profile
12.5.2 Inc Product Introduction
12.5.3 Inc Contraceptives Drugs and Devices Production, Revenue (2015-2020)
12.5.4 SWOT Analysis
12.6 Bayer AG
12.6.1 Bayer AG Company Profile
12.6.2 Bayer AG Product Introduction
12.6.3 Bayer AG Contraceptives Drugs and Devices Production, Revenue (2015-2020)
12.6.4 SWOT Analysis
12.7 Mayer Laboratories
12.7.1 Mayer Laboratories Company Profile
12.7.2 Mayer Laboratories Product Introduction
12.7.3 Mayer Laboratories Contraceptives Drugs and Devices Production, Revenue (2015-2020)
12.7.4 SWOT Analysis
12.8 Merck & Co. Inc
12.8.1 The Female Health Company Company Profile
12.8.2 The Female Health Company Product Introduction
12.8.3 The Female Health Company Contraceptives Drugs and Devices Production, Revenue (2015-2020)
12.8.4 SWOT Analysis
12.9 Cooper Surgical
12.9.1 Cooper Surgical Company Profile
12.9.2 Cooper Surgical Product Introduction
12.9.3 Cooper Surgical Contraceptives Drugs and Devices Production, Revenue (2015-2020)
12.9.4 SWOT Analysis
12.10 Allergan plc
12.10.1 Allergan plc Company Profile
12.10.2 Allergan plc Product Introduction
12.10.3 Allergan plc Contraceptives Drugs and Devices Production, Revenue (2015-2020)
12.10.4 SWOT Analysis
12.11 Cipla Limited
12.12 Merck & Co. Inc
13 Conclusion
Price : US$ 3,500 | Date : Apr 2024 |
Category : Consumer Goods and Retail | Pages : 148 |
Price : US$ 3,500 | Date : Apr 2024 |
Category : Healthcare and Pharmaceuticals | Pages : 96 |
Price : US$ 2,450 | Date : Feb 2024 |
Category : Healthcare and Pharmaceuticals | Pages : 221 |
Price : US$ 3,800 | Date : Feb 2024 |
Category : Healthcare and Pharmaceuticals | Pages : 175 |
Price : US$ 3,500 | Date : Mar 2024 |
Category : Medical Devices | Pages : 160 |
We will be happy to help you find what you need. Please call us or write to us: